Pérdida de masa ósea en pacientes con cáncer de próstata sometidos a deprivación androgénica

following applicable recommendations, urologists must carefully monitor the bone health of patients with prostate cancer subjected to androgenic deprivation, in order to obtain an early diagnosis and to apply the appropriate general and/or therapeutic measures, if necessary.